Nasalvicks (Oxymetazoline Hydrochloride)

Oxymetazoline, the active ingredient in Nasalvicks, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It provides rapid relief of nasal congestion by constricting blood vessels in the nasal mucosa, helping to reduce swelling and improve airflow in adults and children.

GNH USA supplies Nasalvicks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other health‑care providers worldwide. Our distribution network ensures consistent quality and regulatory compliance across regions. We adhere to stringent manufacturing standards and provide reliable logistics support.

Oxymetazoline is a topical nasal decongestant that acts on the alpha‑adrenergic receptors of the nasal mucosa.

- Common cold: reduces nasal blockage and improves breathing. - Allergic rhinitis: alleviates congestion associated with seasonal allergies. - Sinusitis: helps relieve sinus pressure and nasal congestion.

Oxymetazoline may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing. - Headache. - Transient hypertension. - Rebound congestion with prolonged use.

Serious or Rare Side Effects: - Severe hypertension. - Tachycardia or arrhythmia. - Allergic reactions such as rash, itching or swelling. - Nasal ulceration. - Vision disturbances. - Chest pain.

Before using Nasalvicks, consider the following safety measures.

- Use in children under 6 years: not recommended unless directed by a healthcare professional. - Avoid prolonged use: limit to three consecutive days to prevent rebound congestion. - Patients with hypertension: monitor blood pressure regularly. - Pregnancy and breastfeeding: consult a healthcare professional; safety has not been established. - Drug interactions: avoid concomitant use with monoamine oxidase inhibitors. - Store at room temperature: keep in the original container, protect from moisture and heat.

Oxymetazoline may interact with other sympathomimetic agents and certain medications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance cardiovascular effects. - Other nasal decongestants: increased risk of rebound congestion. - Sympathomimetic drugs (e.g., epinephrine): additive systemic stimulation.